Director Market Access

## Director Market Access UKApplylocations:
UK - Remote time type:
Full time posted on:
Posted Todayjob requisition :
REQ-4425
* Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases.
* * We are building a new kind of biotech company, one that maintains its roots as a science-based start-up and pushes our commitment to innovate across all corners of our business. We strive to inspire and grow our company, our partnerships, our science, and our people, because when we do, we deliver more for patients.
* For the expansion of our market access team, argenx is looking for a Director, Market Access, UK.
** The role
** A rare opportunity to shape the reimbursement and access strategy for one of the most innovative immunology companies, with multiple launches and indications expected over the coming years
* A highly visible role with significant influence across the UK leadership team and global organisation, offering real ownership rather than execution alone;
* Acting as an enterprise thinker to develop a strategic UK voice / perspective and ensure that it is represented within the global access team;
* Optimising the late stage argenx pipeline, providing an opportunity to build, rather than simply maintain, market access strategies across several disease areas;
* Shaping future access pathways:
The UK is entering a period of significant change, with MHRA and NICE reforms creating important ecosystem / policy opportunities to position the UK as a leading launch market.
** PURPOSE OF THE FUNCTION
** The UK Market Access Director will be responsible for leading pricing, reimbursement, market access, and policy activities across the UK & Ireland, and execution across all payer and distribution channels.

More broadly, the UK MA Director will be a dotted-line member of the global argenx Market Access team, supporting global market access initiatives and working in close collaboration with other functions and select local-country teams.
** ROLES AND RESPONSIBILITIES
*** Develop innovative UK & Ireland pricing and access strategies that are of high quality, based on value delivered and that are fit for purpose;
* Have deep country-level understanding of UK payer needs, decision-making approaches, strategies, and country reimbursement stakeholders and influencers;
* External engagement:
Partner with the broader UK & Ireland life sciences ecosystems (NICE, SMC, NCPE, MHRA, Westminster, etc.) and industry groups (e.g. EMG);
* Collaborate with the UK Senior Leadership Team on the local pricing & reimbursement processes in the UK & Ireland;
* Coordinate the negotiation strategy for UK & Ireland, with a clearly defined negotiation approach, in close collaboration with the UK Senior Leadership Team and other functions as needed;
* Establish and maintain personal relationships with select payers, advisors, key opinion leaders and other stakeholders;
* Support the development of health economic and outcomes analyses (CEA, BIA, burden of disease, etc.) required for access, working in collaboration with internal cross-functional teams in medical affairs, evidence generation, HEORand R&D;
* Develop compliant communication tools to be used in discussions with payers;
* Leads internal & external providers to ensure that Market Access deliverables are suitable for purpose & available in a timely fashion;
* Evaluates market access & P&R environmental developments.
** SKILLS AND COMPETENCIES
*** Strong cross-functional business partnership.  Ability to work collaboratively and effectively together within cross-functional teams and networks;
* Ability to grasp highly technical concepts and to work within a deeply scientific environment;
Exceptional learning agility, demonstrated by advancement in prior roles/companies ;
* Direct experience negotiating with payers and securing positive HTA outcomes in the UK (NICE / SMC) and Ireland (NCPE);
* Experience working within launch and commercialisation teams for therapies in the orphan and rare disease space in the UK;
* First-rate analytical ability, with a track record of using data to inform decision-making;
* Is agile and demonstrates adaptability, comfort with ambiguity, trust-building, and resilience;
* Derives energy from operating in a dynamic, complex, fast-moving, and frequently changing business environment;
* Demonstrable experience with project management, proactive planning, priority setting, and securing alignment;
* Drives toward outcomes;
* Ambitious, inquisitive naturally, a quick study, with demonstrated eagerness to continuously learn, self-improve and develop. This includes being comfortable giving and receiving feedback in a diverse environment;
*…